Medtronic's MiniMed 670G - the closest thing yet to an artificial pancreas - has been launched in the US. The so-called 'hybrid closed-loop' system comprises a blood glucose sensor ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

Roche is teaming up with two medical tech companies to develop an automated insulin delivery system, the first steps towards an ‘artificial pancreas.’ The Swiss pharma will work with existing ...

Medtronic has agreed to be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes devices that provide revascularization treatment for carotid and peripheral vascular disease.

Medtronic’s Percept PC neurostimulator with BrainSense technology [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced today that it received CE mark approval for its BrainSense ...

Medtronic India Pvt. Ltd. began operations in India in 1979. It is the wholly owned subsidiary of Medtronic Plc, an American Irish medical devices company. The company has presence across India in ...

Martha described Medtronic’s new Simplera Sync sensor as “half the size and much easier to apply than our previous sensor,” and said there are more sensors in the pipeline, as well as next-generation ...

Medtronic (NYSE: MDT) + announced today that it entered into an exclusive U.S. distribution agreement with Contego Medical. Under the agreement, Medtronic serves as the sole U.S. distributor for ...

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices giant had some weakness in recent years amid disappointing trends from ...

At the 43rd annual J.P. Morgan Healthcare Conference on Monday, Medtronic CEO Geoff Martha mixed in some breaking news with his usual pitch to investors. Just hours earlier, the Centers for ...